Disease Control Priorities Third Edition Volume 4

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.

Produk Detail:

  • Author : Vikram Patel
  • Publisher : World Bank Publications
  • Pages : 304 pages
  • ISBN : 1464804281
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKDisease Control Priorities Third Edition Volume 4

Disease Control Priorities, Third Edition (Volume 4)

Disease Control Priorities, Third Edition (Volume 4)
  • Author : Vikram Patel,Dan Chisholm,Tarun Dua,Ramanan Laxminarayan,Mari'a Lena Medina-Mora,Theo Vos
  • Publisher : World Bank Publications
  • Release : 10 March 2016
GET THIS BOOKDisease Control Priorities, Third Edition (Volume 4)

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this

Marijuana As Medicine?

Marijuana As Medicine?
  • Author : Institute of Medicine,Janet Joy,Alison Mack
  • Publisher : National Academies Press
  • Release : 30 December 2000
GET THIS BOOKMarijuana As Medicine?

Some people suffer from chronic, debilitating disorders for which no conventional treatment brings relief. Can marijuana ease their symptoms? Would it be breaking the law to turn to marijuana as a medication? There are few sources of objective, scientifically sound advice for people in this situation. Most books about marijuana and medicine attempt to promote the views of advocates or opponents. To fill the gap between these extremes, authors Alison Mack and Janet Joy have extracted critical findings from a

A Paradigm Shift to Prevent and Treat Alzheimer's Disease

A Paradigm Shift to Prevent and Treat Alzheimer's Disease
  • Author : Howard Friel,Sally A. Frautschy
  • Publisher : Academic Press
  • Release : 18 July 2017
GET THIS BOOKA Paradigm Shift to Prevent and Treat Alzheimer's Disease

A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols is the first book to systematically exhibit the powerful pleiotropic pharmacological effects on Alzheimer’s disease of plant-based compounds from ancient foods that humans have been consuming safely with substantial health benefits for thousands of years. These plant-based compounds include curcuminoids from turmeric, resveratrol from red wine and grape seed extract from other grape products, epigallocatechin-gallate (EGCG) from green tea, and oleocanthal and

Memory Loss, Alzheimer's Disease, and Dementia E-Book

Memory Loss, Alzheimer's Disease, and Dementia E-Book
  • Author : Andrew E. Budson,Paul R. Solomon
  • Publisher : Elsevier Health Sciences
  • Release : 20 May 2015
GET THIS BOOKMemory Loss, Alzheimer's Disease, and Dementia E-Book

Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon — both key leaders in the field — cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of

The End of Alzheimer's Program

The End of Alzheimer's Program
  • Author : Dale Bredesen
  • Publisher : Penguin
  • Release : 18 August 2020
GET THIS BOOKThe End of Alzheimer's Program

The instant New York Times bestseller The New York Times Best Selling author of The End of Alzheimer's lays out a specific plan to help everyone prevent and reverse cognitive decline or simply maximize brainpower. In The End of Alzheimer's Dale Bredesen laid out the science behind his revolutionary new program that is the first to both prevent and reverse symptoms of Alzheimer's disease. Now he lays out the detailed program he uses with his own patients. Accessible and detailed,

The Spectrum of Hope

The Spectrum of Hope
  • Author : Gayatri Devi
  • Publisher : Workman Publishing
  • Release : 31 October 2017
GET THIS BOOKThe Spectrum of Hope

Imagine finding a glimmer of good news in a diagnosis of Alzheimer’s. And imagine how that would change the outlook of the 5 million Americans who suffer from Alzheimer’s disease and other dementias, not to mention their families, loved ones, and caretakers. A neurologist who’s been specializing in dementia and memory loss for more than 20 years, Dr. Gayatri Devi rewrites the story of Alzheimer’s by defining it as a spectrum disorder—like autism, Alzheimer’s is a

Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology

Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology
  • Author : Carol Brayne,Professor of Public Health Medicine and Director of the Cambridge University Department of Public Health Carol Brayne,Director National Institute for Stroke and Applied Neuroscience (Nisan) Valery Feigin,Valery Feigin,Lenore Launer,Giancarlo Logroscino
  • Publisher : Oxford University Press, USA
  • Release : 02 November 2020
GET THIS BOOKOxford Textbook of Neurologic and Neuropsychiatric Epidemiology

The Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology focuses on the overlaps between neuro-epidemiological disorders. Harmonising cohort studies to determine causes related to rarer disorders, this key work is an invaluable reference to current neuro-epidemiological methods.

Neurochemical Aspects of Alzheimer's Disease

Neurochemical Aspects of Alzheimer's Disease
  • Author : Akhlaq A. Farooqui
  • Publisher : Academic Press
  • Release : 25 May 2017
GET THIS BOOKNeurochemical Aspects of Alzheimer's Disease

Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and therapeutic strategies of AD. The comprehensive and cutting edge information in this monograph may not only help in early detection of AD, but also promote discovery of new drugs to treat this chronic disease. Chapters discuss involvement of neural membrane phospholipids, sphingolipids, and cholesterol-derived

Alzheimer's Disease

Alzheimer's Disease
  • Author : Renee D. Wegrzyn,Alan S. Rudolph
  • Publisher : CRC Press
  • Release : 26 April 2012
GET THIS BOOKAlzheimer's Disease

In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimer’s disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimer’s Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a detailed synopsis of the current state of the art of diagnostics and therapeutics and identifies emerging technologies and molecules that show promise in the management and treatment of AD. With contributions from experts drawn from

Neurological Disorders

Neurological Disorders
  • Author : World Health Organization
  • Publisher : World Health Organization
  • Release : 17 April 2021
GET THIS BOOKNeurological Disorders

Although there are several gaps in understanding the many issues related to neurological disorders, we know enough to be able to shape effective policy responses to some of the most common. This book describes and discusses the increasing public health impact of common neurological disorders such as dementia, epilepsy, headache disorders, multiple sclerosis, neuroinfections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson's disease, stroke and traumatic brain injuries. It provides information and advice on public health interventions

The Dementias: Hope Through Research (Revised December 2017)

The Dementias: Hope Through Research (Revised December 2017)
  • Author : U.S. Department of Health and Human Services
  • Publisher : Lulu.com
  • Release : 13 April 2019
GET THIS BOOKThe Dementias: Hope Through Research (Revised December 2017)

Dementia is the loss of cognitive functioning?the ability to think, remember, or reason?to such an extent that it interferes with a person's daily life and activities. These functions include memory, language skills, visual perception, problem solving, self-management, and the ability to focus and pay attention. Some people with dementia cannot control their emotions, and their personalities may change. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person's functioning, to the

Principles of Drug Therapy in Neurology

Principles of Drug Therapy in Neurology
  • Author : Michael V. Johnston,Robert Gross
  • Publisher : Oxford University Press
  • Release : 01 May 2008
GET THIS BOOKPrinciples of Drug Therapy in Neurology

Since the first edition of this book was published in 1992, the number of pharmacological therapies available for treating neurological disorders has grown exponentialy. This new edition brings the book fully up-to-date, and features PET scans to illustrate brain action, and new chapters on practical therapeutics and clinical trials.

Neuroprotection in Autism, Schizophrenia and Alzheimer's disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's disease
  • Author : Illana Gozes,Joseph Levine
  • Publisher : Academic Press
  • Release : 16 October 2019
GET THIS BOOKNeuroprotection in Autism, Schizophrenia and Alzheimer's disease

Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease provides an up-to-date overview on recent clinical studies and the similarities discovered in the most prevalent brain disorders. The book's content will help shed light on basic mechanisms and provide new avenues for early diagnosis toward disease prevention and disease modification. It is written for researchers, clinicians and medical physicians in neuroscience, neurology and psychiatry. Sections discuss the shared pathophysiological mechanisms that underlie autism, schizophrenia/mood disorders and Alzheimer’s disease, i.e.